BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25104845)

  • 1. Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke.
    Muchada M; Rodriguez-Luna D; Pagola J; Flores A; Sanjuan E; Meler P; Boned S; Alvarez-Sabin J; Ribo M; Molina CA; Rubiera M
    Stroke; 2014 Sep; 45(9):2734-8. PubMed ID: 25104845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.
    Saqqur M; Uchino K; Demchuk AM; Molina CA; Garami Z; Calleja S; Akhtar N; Orouk FO; Salam A; Shuaib A; Alexandrov AV;
    Stroke; 2007 Mar; 38(3):948-54. PubMed ID: 17290031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
    Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
    Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion.
    Mendonça N; Rodriguez-Luna D; Rubiera M; Boned-Riera S; Ribo M; Pagola J; Piñeiro S; Meler P; Alvarez-Sabin J; Montaner J; Molina CA
    Stroke; 2012 Feb; 43(2):417-21. PubMed ID: 22135072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hill MD; Alexandrov AV;
    Stroke; 2007 Mar; 38(3):961-6. PubMed ID: 17255548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke.
    Barreto AD; Alexandrov AV; Shen L; Sisson A; Bursaw AW; Sahota P; Peng H; Ardjomand-Hessabi M; Pandurengan R; Rahbar MH; Barlinn K; Indupuru H; Gonzales NR; Savitz SI; Grotta JC
    Stroke; 2013 Dec; 44(12):3376-81. PubMed ID: 24159060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion.
    Alvarez-Sabín J; Molina CA; Ribó M; Arenillas JF; Montaner J; Huertas R; Santamarina E; Rubiera M
    Stroke; 2004 Nov; 35(11):2493-8. PubMed ID: 15472110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis.
    Rubiera M; Ribo M; Delgado-Mederos R; Santamarina E; Delgado P; Montaner J; Alvarez-Sabín J; Molina CA
    Stroke; 2006 Sep; 37(9):2301-5. PubMed ID: 16888266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis.
    Ribo M; Molina CA; Alvarez B; Rubiera M; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2010 Jul; 20(3):224-7. PubMed ID: 19226340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion.
    Pagola J; Ribo M; Alvarez-Sabín J; Lange M; Rubiera M; Molina CA
    Stroke; 2007 Nov; 38(11):2931-4. PubMed ID: 17901389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke.
    Muchada M; Rubiera M; Rodriguez-Luna D; Pagola J; Flores A; Kallas J; Sanjuan E; Meler P; Alvarez-Sabin J; Ribo M; Molina CA
    Stroke; 2014 Apr; 45(4):1059-63. PubMed ID: 24603070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.
    Smadja D; Chausson N; Joux J; Saint-Vil M; Signaté A; Edimonana M; Jeannin S; Bartoli B; Aveillan M; Cabre P; Olindo S
    Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
    Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM
    Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.
    Ribo M; Molina C; Montaner J; Rubiera M; Delgado-Mederos R; Arenillas JF; Quintana M; Alvarez-Sabín J
    Stroke; 2005 Aug; 36(8):1705-9. PubMed ID: 16002761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.